Early Detection of Mild Cognitive Impairment (MCI) in an At-Home Setting

• Published in: Journal of Prevention of Alzheimer's Disease, The Vol. 7; no. 3; pp. 171 - 178
• Main Authors: Sabbagh, Marwan N, Boada, M, Borson, S, Doraiswamy, P.M, Dubois, B, Ingram, J, Iwata, A, Porsteinsson, A.P, Possin, K.L, Rabinovici, G.D, Vellas, B, Chao, S, Vergallo, A, Hampel, H
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.06.2020; SERDI éd
• Subjects: Alzheimer Disease - diagnosis; Cognitive Dysfunction - diagnosis; Digital Technology; Direct-To-Consumer Screening and Testing - standards; Early Diagnosis; Geriatrics/Gerontology; Humans; Life Sciences; Mass Screening - instrumentation; Medicine; Medicine & Public Health; Mental Status and Dementia Tests - standards; Mobile Applications; Neurology; Reviews; Santé publique et épidémiologie; mild cognitive impairment; cognitive screening; digital consumer; Alzheimer's disease; Alzheimer’s disease
• ISSN: 2274-5807; 2426-0266; 2426-0266
• DOI: 10.14283/jpad.2020.22

AbstractEmerging digital tools have the potential to enable a new generation of qualitative and quantitative assessment of cognitive performance. Moreover, the ubiquity of consumer electronics, such as smartphones and tablets, can be harnessed to support large-scale self-assessed cognitive screening with benefit to healthcare systems and consumers. A wide variety of apps, wearables, and new digital technologies are either available or in development for the detection of mild cognitive impairment (MCI), a risk factor for dementia. Two categories of novel methodologies may be considered: passive technologies (which monitor a user' behavior without active user input) and interactive assessments (which require active user input). Such examinations can be self-administered, supervised by a caregiver, or conducted by an informant at home or outside of a clinical setting. These direct-to-consumer tools have the potential to sidestep barriers associated with cognitive evaluation in primary care, thus improving access to cognitive assessments. Although direct-to-consumer cognitive assessment is associated with its own barriers, including test validation, user experience, and technological concerns, it is conceivable that these issues can be addressed so that a large-scale, selfassessed cognitive evaluation that would represent an initial cognitive screen may be feasible in the future.